You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 268 Development of FT825/ONO-8250: an off-the-shelf CAR-T cell with preferential HER2 targeting and engineered to enable multi-antigen targeting, improve trafficking, and overcome immunosuppression

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
268 Development of FT825/ONO-8250: an off-the-shelf CAR-T cell with preferential HER2 targeting and engineered to enable multi-antigen targeting, improve trafficking, and overcome immunosuppression

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023284018
Dec 202387010
Jan 202410007
Feb 202411808
Mar 20244405
Apr 202470010
May 20243602
Jun 20244601
Jul 20244606
Aug 20248506
Sep 20244603
Oct 202452010
Nov 20248809
Dec 202486015
Jan 202586011
Feb 20251706
Mar 20250012
Apr 2025002
May 2025003
Jun 2025005
Total12910149